Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dimeticone, also known as polydimethylsiloxane or PDMS, is a synthetic silicone oil widely used in pharmaceuticals, cosmetics, and medical devices. It acts primarily as an occlusive and emollient agent by forming a hydrophobic film on the skin surface to prevent transepidermal water loss. In topical applications, it is used to treat dry skin conditions and minor irritations by moisturizing and protecting the skin. As an anti-flatulent agent when ingested, it reduces surface tension of gas bubbles in the gastrointestinal tract to facilitate their expulsion. Dimeticone is also approved for use as a physical pediculicide for head lice; it kills lice through suffocation by coating their respiratory system with its viscous solution—a mechanism that makes resistance development unlikely. Dimeticone is considered non-toxic and physiologically inert in humans[1][4][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dimeticone.